Gammadelta (γδ) T lymphocytes respond quickly upon antigen encounter to produce a cytokine response. In this study, we sought to understand how functions of γδ T cells are differentially regulated compared to αβ T cells. We found that cholesterol, an integral component of the plasma membrane and a regulator of TCR signaling, is increased in γδ T cells compared to αβ T cells, and modulates their function. Higher levels of activation markers, and increased lipid raft content in γδ cells suggest that γδ T cells are more activated. Cholesterol depletion effectively decreased lipid raft formation and activation of γδ T cells, indicating that increased cholesterol content contributes to the hyper-activated phenotype of γδ T cells, possibly through enhanced clustering of TCR signals in lipid rafts. TCR stimulation assays and western blotting revealed that instead of a lower TCR threshold, enhanced TCR signaling through ERK1/2 activation is likely the cause for high cholesterol-induced rapid activation and proliferation in γδ T cells. Our data indicate that cholesterol metabolism is differentially regulated in γδ T cells. The high intracellular cholesterol content leads to enhanced TCR signaling and increases activation and proliferation of γδ T cells.
References
[1]
Inghirami G, Zhu BY, Chess L, Knowles DM (1990) Flow cytometric and immunohistochemical characterization of the gamma/delta T-lymphocyte population in normal human lymphoid tissue and peripheral blood. The American journal of pathology 136: 357–367.
[2]
Champagne E (2011) gammadelta T cell receptor ligands and modes of antigen recognition. Archivum immunologiae et therapiae experimentalis 59: 117–137.
[3]
Kapsenberg ML (2009) Gammadelta T cell receptors without a job. Immunity 31: 181–183.
[4]
Eberl M, Moser B (2009) Monocytes and gammadelta T cells: close encounters in microbial infection. Trends in immunology 30: 562–568.
[5]
Fang H, Welte T, Zheng X, Chang GJ, Holbrook MR, et al. (2010) gammadelta T cells promote the maturation of dendritic cells during West Nile virus infection. FEMS immunology and medical microbiology 59: 71–80.
[6]
Brandes M, Willimann K, Bioley G, Levy N, Eberl M, et al. (2009) Cross-presenting human gammadelta T cells induce robust CD8+ alphabeta T cell responses. Proceedings of the National Academy of Sciences of the United States of America 106: 2307–2312.
[7]
Graff JC, Behnke M, Radke J, White M, Jutila MA (2006) A comprehensive SAGE database for the analysis of gammadelta T cells. Int Immunol 18: 613–626.
[8]
Shires J, Theodoridis E, Hayday AC (2001) Biological insights into TCRgammadelta+ and TCRalphabeta+ intraepithelial lymphocytes provided by serial analysis of gene expression (SAGE). Immunity 15: 419–434.
[9]
Laird RM, Hayes SM (2009) Profiling of the early transcriptional response of murine gammadelta T cells following TCR stimulation. Mol Immunol 46: 2429–2438.
[10]
Fahrer AM, Konigshofer Y, Kerr EM, Ghandour G, Mack DH, et al. (2001) Attributes of gammadelta intraepithelial lymphocytes as suggested by their transcriptional profile. Proc Natl Acad Sci U S A 98: 10261–10266.
[11]
Jameson JM, Cruz J, Costanzo A, Terajima M, Ennis FA (2010) A role for the mevalonate pathway in the induction of subtype cross-reactive immunity to influenza A virus by human gammadelta T lymphocytes. Cellular immunology 264: 71–77.
[12]
Gombos I, Kiss E, Detre C, Laszlo G, Matko J (2006) Cholesterol and sphingolipids as lipid organizers of the immune cells' plasma membrane: their impact on the functions of MHC molecules, effector T-lymphocytes and T-cell death. Immunol Lett 104: 59–69.
[13]
Surls J, Nazarov-Stoica C, Kehl M, Olsen C, Casares S, et al. (2012) Increased Membrane Cholesterol in Lymphocytes Diverts T-Cells toward an Inflammatory Response. PloS one 7: e38733.
[14]
Armstrong AJ, Gebre AK, Parks JS, Hedrick CC (2010) ATP-binding cassette transporter G1 negatively regulates thymocyte and peripheral lymphocyte proliferation. J Immunol 184: 173–183.
[15]
Major AS, Wilson MT, McCaleb JL, Ru Su Y, Stanic AK, et al. (2004) Quantitative and qualitative differences in proatherogenic NKT cells in apolipoprotein E-deficient mice. Arteriosclerosis, thrombosis, and vascular biology 24: 2351–2357.
[16]
Rudel LL, Kelley K, Sawyer JK, Shah R, Wilson MD (1998) Dietary monounsaturated fatty acids promote aortic atherosclerosis in LDL receptor-null, human ApoB100-overexpressing transgenic mice. Arteriosclerosis, thrombosis, and vascular biology 18: 1818–1827.
[17]
Bensinger SJ, Bradley MN, Joseph SB, Zelcer N, Janssen EM, et al. (2008) LXR signaling couples sterol metabolism to proliferation in the acquired immune response. Cell 134: 97–111.
[18]
Zhang DW, Garuti R, Tang WJ, Cohen JC, Hobbs HH (2008) Structural requirements for PCSK9-mediated degradation of the low-density lipoprotein receptor. Proceedings of the National Academy of Sciences of the United States of America 105: 13045–13050.
[19]
Greenspan P, Mayer EP, Fowler SD (1985) Nile red: a selective fluorescent stain for intracellular lipid droplets. The Journal of cell biology 100: 965–973.
[20]
Diaz G, Melis M, Batetta B, Angius F, Falchi AM (2008) Hydrophobic characterization of intracellular lipids in situ by Nile Red red/yellow emission ratio. Micron 39: 819–824.
[21]
Jury EC, Kabouridis PS, Flores-Borja F, Mageed RA, Isenberg DA (2004) Altered lipid raft-associated signaling and ganglioside expression in T lymphocytes from patients with systemic lupus erythematosus. J Clin Invest 113: 1176–1187.
[22]
Jury EC, Flores-Borja F, Kabouridis PS (2007) Lipid rafts in T cell signalling and disease. Semin Cell Dev Biol 18: 608–615.
[23]
Kabouridis PS, Jury EC (2008) Lipid rafts and T-lymphocyte function: implications for autoimmunity. FEBS Lett 582: 3711–3718.
[24]
Lu HZ, Zhu AY, Chen Y, Tang J, Li BQ (2011) Formation and aggregation of lipid rafts in gammadelta T cells following stimulation with Mycobacterium tuberculosis antigens. The Tohoku journal of experimental medicine 223: 193–198.
[25]
Fulop T Jr, Douziech N, Goulet AC, Desgeorges S, Linteau A, et al. (2001) Cyclodextrin modulation of T lymphocyte signal transduction with aging. Mech Ageing Dev 122: 1413–1430.
[26]
Wang X, Xu H, Alvarez X, Pahar B, Moroney-Rasmussen T, et al. (2011) Distinct expression patterns of CD69 in mucosal and systemic lymphoid tissues in primary SIV infection of rhesus macaques. PloS one 6: e27207.
[27]
Whetzel AM, Sturek JM, Nagelin MH, Bolick DT, Gebre AK, et al. (2010) ABCG1 deficiency in mice promotes endothelial activation and monocyte-endothelial interactions. Arterioscler Thromb Vasc Biol 30: 809–817.
[28]
Tarling EJ, Edwards PA (2011) ATP binding cassette transporter G1 (ABCG1) is an intracellular sterol transporter. Proceedings of the National Academy of Sciences of the United States of America 108: 19719–19724.
[29]
Moser B, Eberl M (2011) gammadelta T-APCs: a novel tool for immunotherapy? Cellular and molecular life sciences : CMLS 68: 2443–2452.
[30]
Chen Y, Ci X, Gorentla B, Sullivan SA, Stone JC, et al. (2012) Differential Requirement of RasGRP1 for gammadelta T Cell Development and Activation. Journal of immunology 189: 61–71.
[31]
Li D, Molldrem JJ, Ma Q (2009) LFA-1 regulates CD8+ T cell activation via T cell receptor-mediated and LFA-1-mediated Erk1/2 signal pathways. The Journal of biological chemistry 284: 21001–21010.
[32]
Wong GW, Zuniga-Pflucker JC (2010) gammadelta and alphabeta T cell lineage choice: resolution by a stronger sense of being. Seminars in immunology 22: 228–236.
[33]
Born WK, Yin Z, Hahn YS, Sun D, O'Brien RL (2010) Analysis of gamma delta T cell functions in the mouse. Journal of immunology 184: 4055–4061.
[34]
Gao YL, Rajan AJ, Raine CS, Brosnan CF (2001) gammadelta T cells express activation markers in the central nervous system of mice with chronic-relapsing experimental autoimmune encephalomyelitis. J Autoimmun 17: 261–271.
[35]
Tough DF, Sprent J (1998) Lifespan of gamma/delta T cells. The Journal of experimental medicine 187: 357–365.
[36]
Do JS, Fink PJ, Li L, Spolski R, Robinson J, et al. (2010) Cutting edge: spontaneous development of IL-17-producing gamma delta T cells in the thymus occurs via a TGF-beta 1-dependent mechanism. Journal of immunology 184: 1675–1679.
[37]
Kenworthy AK (2008) Have we become overly reliant on lipid rafts? Talking Point on the involvement of lipid rafts in T-cell activation. EMBO reports 9: 531–535.
[38]
Kabouridis PS, Janzen J, Magee AL, Ley SC (2000) Cholesterol depletion disrupts lipid rafts and modulates the activity of multiple signaling pathways in T lymphocytes. European journal of immunology 30: 954–963.
[39]
Jensen KD, Chien YH (2009) Thymic maturation determines gammadelta T cell function, but not their antigen specificities. Curr Opin Immunol 21: 140–145.
[40]
Jensen KD, Su X, Shin S, Li L, Youssef S, et al. (2008) Thymic selection determines gammadelta T cell effector fate: antigen-naive cells make interleukin-17 and antigen-experienced cells make interferon gamma. Immunity 29: 90–100.
[41]
Ribot JC, deBarros A, Pang DJ, Neves JF, Peperzak V, et al. (2009) CD27 is a thymic determinant of the balance between interferon-gamma- and interleukin 17-producing gammadelta T cell subsets. Nature immunology 10: 427–436.
[42]
Ribot JC, Chaves-Ferreira M, d'Orey F, Wencker M, Goncalves-Sousa N, et al. (2010) Cutting edge: adaptive versus innate receptor signals selectively control the pool sizes of murine IFN-gamma- or IL-17-producing gammadelta T cells upon infection. Journal of immunology 185: 6421–6425.
[43]
Martin B, Hirota K, Cua DJ, Stockinger B, Veldhoen M (2009) Interleukin-17-producing gammadelta T cells selectively expand in response to pathogen products and environmental signals. Immunity 31: 321–330.
[44]
Sutton CE, Mielke LA, Mills KH (2012) IL-17-producing gammadelta T cells and innate lymphoid cells. European journal of immunology 42: 2221–2231.
[45]
Murdoch JR, Lloyd CM (2010) Resolution of allergic airway inflammation and airway hyperreactivity is mediated by IL-17-producing {gamma}{delta}T cells. American journal of respiratory and critical care medicine 182: 464–476.
[46]
Smith E, Prasad KM, Butcher M, Dobrian A, Kolls JK, et al. (2010) Blockade of interleukin-17A results in reduced atherosclerosis in apolipoprotein E-deficient mice. Circulation 121: 1746–1755.
